Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05282628 · ClinicalTrials.gov registry record · NA
I-InTERACT Preterm
A NA study of Pre-Term, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT05282628: Active NA study of Pre-Term, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT05282628 is a NA study of Pre-Term that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 19 participants, below the 163-participant average among 4 other Pre-Term trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05282628, a NA study of Pre-Term, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Open pilot of a brief online parenting-skills intervention for young children ages 3-8 who were born very preterm (\< 32 weeks gestational age). Parent-child interactions, child behavior, parent functioning, and child white matter connectivity will be assessed pre- and post-intervention 10 weeks later.
Conditions Studied
Interventions
- BEHAVIORAL Building Better Brains and Behavior program (B4 Preterm)
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT05282628 still lists
NCT05282628 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 163-participant average among 4 other Pre-Term trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Pre-Term appearing as the primary indexed condition, and to 1 intervention - of which Building Better Brains and Behavior program (B4 Preterm) is the first listed.
NCT05282628 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05282628 about?
NCT05282628 is a clinical study titled "I-InTERACT Preterm". Open pilot of a brief online parenting-skills intervention for young children ages 3-8 who were born very preterm (\< 32 weeks gestational age). Parent-child interactions, child behavior, parent functioning, and child white matter connectivity will be assessed pre- and post-intervention 10 weeks lat...
What is the current status of trial NCT05282628?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2021-09-01. Estimated completion is 2026-08-31.
What conditions does trial NCT05282628 study?
This clinical trial studies the following conditions: Pre-Term.
What interventions are being tested in trial NCT05282628?
The interventions under investigation include: Building Better Brains and Behavior program (B4 Preterm) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05282628?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05282628 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre-Term
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI